文献速递关节外科创伤骨科

慢性髋关节假体周围感染清创及间隔物置入相关的肾毒性

Renal Toxicity Associated With Resection and Spacer Insertion for Chronic Hip PJI.
PubMed 文献 · J Arthroplasty · 2021-04-21

本研究回顾性分析了2000至2017年间227例因感染性全髋关节置换术后行清创及抗生素骨水泥间隔物置入的患者,评估急性肾损伤(AKI)的发生率、危险因素及结局。

要点

  • 无CKD患者AKI发生率为7%,合并CKD者高达28%,风险增加5倍。
  • 术后液体不足、ICU需求及急性房颤是无CKD患者AKI的独立预测因素。
  • 间隔物留置时间、骨水泥抗生素剂量、两性霉素B使用及静脉抗生素类型非显著危险因素。

核心结论

  • 无CKD患者AKI发生率为7%,合并CKD者风险增加5倍,4%的AKI进展为CKD。
  • 急性肾血流受损的原因是无CKD患者AKI的独立预测因素。

研究设计与样本

  • 回顾性比较研究,纳入2000至2017年间227例因感染性全髋关节置换术后行清创及抗生素骨水泥间隔物置入的患者,共256个间隔物。

主要发现

  • 无患者需要急性透析。
  • 间隔物留置时间、骨水泥平均抗生素剂量、两性霉素B使用及静脉抗生素类型不是显著危险因素。
  • 末次随访时8例AKI进展为CKD,其中1例在7年后接受透析。

关键数值与推荐

  • AKI定义为肌酐≥1.5倍基线或≥0.3 mg/dL。
  • 平均年龄65岁,平均体重指数30 mg/kg2,55%为男性,16%有既往CKD。
  • 间隔物平均留置15周,伴随静脉或口服抗生素平均6周,平均随访8年。

临床怎么用

  • 对慢性髋关节假体周围感染行清创及间隔物置入的患者,应关注术后液体状态、ICU需求及急性房颤以预防AKI。
  • 合并CKD的患者AKI风险更高,需加强肾功能监测。

局限性

  • 回顾性研究设计。
  • 证据等级为III级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Two-stage exchange arthroplasty with high-dose antibiotic-loaded bone cement spacer and intravenous (IV) antibiotics is the most common method of managing infected total hip arthroplasties. However, the contemporary incidence, risk factors, and outcomes of acute kidney injuries (AKIs) in this cohort are unknown. METHODS: We identified 227 patients treated with 256 antibiotic-loaded bone cement spacers after resection of an infected primary total hip arthroplasty between 2000 and 2017. Mean age was 65 years, mean body mass index was 30 mg/kg2, 55% were men, and 16% had pre-existing chronic kidney disease (CKD). Spacers were in situ for a mean of 15 weeks, concomitantly associated with IV or oral antibiotics for a mean of 6 weeks. AKI was defined as a creatinine ≥1.5X baseline or ≥0.3 mg/dL. Mean follow-up was 8 years. RESULTS: AKI occurred in 13 patients without pre-existing CKD (7%) vs 10 patients with CKD (28%; OR 5; P = .0001). None required acute dialysis. Postoperative fluid depletion (β = 0.31; P = .0001), ICU requirement (β = 0.40; P = .0001), and acute atrial fibrillation (β = 0.43; P = .0001) were independent predictors for AKI in patients without pre-existing CKD. Duration of in situ spacer, mean antibiotic dose in cement, use of amphotericin B, and type of IV antibiotics were not significant risk factors. At last follow-up, 8 AKIs progressed to CKD, with one receiving dialysis 7 years later. CONCLUSION: AKIs occurred in 7% of patients with normal renal function, with 5-fold greater risk in those with CKD, and 4% did develop CKD. Importantly, causes of acute renal blood flow impairment were independent predictors for AKI. LEVEL OF EVIDENCE: Level III, comparative study.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Dagneaux L, Limberg AK, Osmon DR, et al. Renal Toxicity Associated With Resection and Spacer Insertion for Chronic Hip PJI. J Arthroplasty. 2021. PMID: 33933331. doi:10.1016/j.arth.2021.04.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。